Zobrazeno 1 - 10
of 282
pro vyhledávání: ''
Publikováno v:
Value in Health. 24:1279-1284
Objectives Health systems (nonfederal hospitals and clinics) are the second major source for drug expenditure in the United States. Opioids prescribed in these healthcare settings are commonly short-acting opioids that can lead to persistent opioid u
Autor:
Tim Kampmeier, Abdul Jabbar Omar Alsaleh, Jenny Pham, Stefan Schraag, Martin Westphal, S. Rehberg
Publikováno v:
Value in Health. 24:939-947
Objectives It is not known whether using propofol total intravenous anaesthesia (TIVA) to reduce incidence of postoperative nausea and vomiting (PONV) is cost-effective. We assessed the economic impact of propofol TIVA versus inhalational anesthesia
Autor:
Michael N Dalili, José A López-López, Deborah M Caldwell, Kyla H Thomas, Mark Stevenson, David Phillippo, Edna Keeney, Nicky J Welton, Marcus R. Munafò
Publikováno v:
Keeney, E, Welton, N J, Stevenson, M, Dalili, M N, López-López, J A, Caldwell, D M, Phillippo, D M, Munafò, M R & Thomas, K H 2021, ' Cost-Effectiveness Analysis of Smoking Cessation Interventions in the United Kingdom Accounting for Major Neuropsychiatric Adverse Events ', Value in Health, vol. 24, no. 6, pp. 780-788 . https://doi.org/10.1016/j.jval.2020.12.012
Value in Health
Value in Health
OBJECTIVES: Smoking is a leading cause of death worldwide. Cessation aids include varenicline, bupropion, nicotine replacement therapy (NRT), and e-cigarettes at various doses (low, standard and high) and used alone or in combination with each other.
Publikováno v:
Value Health
Objectives To estimate the effect of filgrastim-sndz market entry on patient out-of-pocket costs and claim payments for filgrastim products. Methods This study used a single interrupted time series design with longitudinal, nationally representative,
Publikováno v:
Value in Health. 23:1543-1551
Objectives Reexamine cost-effectiveness of riluzole in the treatment of amyotrophic lateral sclerosis (ALS) in light of recent advances in disease staging and understanding of stage-specific drug effect. Methods ALS was staged according to the “fin
Publikováno v:
Value in Health
Objectives We applied principles for conducting economic evaluations of factorial trials to a trial-based economic evaluation of a cluster-randomized 2 × 2 × 2 factorial trial. We assessed the cost-effectiveness of atorvastatin, omega-3 fish oil, a
Publikováno v:
Value in Health. 23:1292-1299
Objectives Overall survival in chronic myeloid leukemia (CML) in chronic phase is not significantly different by treatment with first-line tyrosine kinase inhibitors (TKIs), but emerging evidence reveals differences in costs and safety profiles. We e
Autor:
Eric K. H. Chan, Elizabeth C. Hsia, John D. Reveille, Stephen Xu, L. Kim, Akgun Ince, Atul Deodhar, Kim Hung Lo, N Li, S. Peterson, Diane D. Harrison, Chenglong Han
Publikováno v:
Value in Health. 23:1281-1285
Evaluate the effect of intravenous golimumab on health-related quality of life (HRQoL) in patients with ankylosing spondylitis (AS) through week 28 of the phase III, multicenter, randomized, double-blind, placebo-controlled GO-ALIVE study.Adult patie
Publikováno v:
Value in Health. 23:710-718
Decision-analytic models for Alzheimer's disease (AD) have been advanced to a discrete-event simulation (DES), in which individual-level modeling of disease progression across continuous severity spectra become feasible. This study aimed to apply DES
Publikováno v:
Value in Health. 23:434-440
Outcomes-based contracts tie rebates and discounts for expensive drugs to outcomes. The objective was to estimate the utility of outcomes-based contracts for diabetes medications using real-world data and to identify methodologic limitations of this